Stopping a trial early in oncology: for patients or for industry?

doi:10.1093/annonc/mdn042

Annals of Oncology Advance Access first published online on February 27, 2008
This version published online on February 29, 2008
Annals of Oncology, doi:10.1093/annonc/mdn042

This Article

	FREE Full Text (PDF)
	All Versions of this Article: 19/7/1347 most recent mdn042v4 mdn042v3 mdn042v2 mdn042v1
	E-letters: Submit a response
	E-letters: View responses
	Alert me when this article is cited
	Alert me when E-letters are posted
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Personal Archive
	Download to citation manager
	Request Permissions
	Disclaimer

Google Scholar

	Search for Related Content

PubMed

	PubMed Citation

Social Bookmarking

	What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Stopping a trial early in oncology: for patients or for industry?

This article was published in error and has been removed.

Add to CiteULike CiteULike Add to Connotea Connotea Add to Del.icio.us Del.icio.us What's this?

This article has been cited by other articles:

E. L. Korn, B. Freidlin, and M. Mooney
Stopping or Reporting Early for Positive Results in Randomized Clinical Trials: The National Cancer Institute Cooperative Group Experience From 1990 to 2005
J. Clin. Oncol., April 1, 2009; 27(10): 1712 - 1721.
[Abstract] [Full Text] [PDF]

S. Garattini and I. Chalmers
Patients and the public deserve big changes in evaluation of drugs
BMJ, March 31, 2009; 338(mar31_3): b1025 - b1025.
[Full Text]

P. Bradbury, R. Meyer, J. Pater, D. Tu, L. Seymour, L. Shepherd, and E. Eisenhauer
Stopping a trial early in oncology: for patients or for industry?
Ann. Onc., February 1, 2009; 20(2): 395 - 396.
[Full Text] [PDF]

J. Whitehead and E. Cobo
Stopping a trial early in oncology: for patients or for industry?
Ann. Onc., August 1, 2008; 19(8): 1512 - 1513.
[Full Text] [PDF]

E-letters:

Read all E-letters

Stopping a trial early in oncology: a further element of discussion.: Antonio Jirillo; Annals of Oncology, 27 May 2008 [Full text]

				S. Garattini and I. Chalmers Patients and the public deserve big changes in evaluation of drugs BMJ, March 31, 2009; 338(mar31_3): b1025 - b1025. [Full Text]

				P. Bradbury, R. Meyer, J. Pater, D. Tu, L. Seymour, L. Shepherd, and E. Eisenhauer Stopping a trial early in oncology: for patients or for industry? Ann. Onc., February 1, 2009; 20(2): 395 - 396. [Full Text] [PDF]

				J. Whitehead and E. Cobo Stopping a trial early in oncology: for patients or for industry? Ann. Onc., August 1, 2008; 19(8): 1512 - 1513. [Full Text] [PDF]